U.S. Senate Minority Leader Charles E. Schumer and U.S. Senator Kirsten Gillibrand today announced $2,775,000 in federal funding for Winifred Masterson Burke Medical Research Institute. The grant was awarded by the U.S. Department of Health and Human Services’ (HHS) National Institute of Neurological Disorders And Stroke (NINDS). The grant will fund clinical research related to neurological disorders; specifically, the modulation of cortical networks, a new approach to spinal cord injury rehabilitation.
“Winifred Masterson Burke Medical Research Institute is a national leader in neurologic research in the Hudson Valley,” said Senator Schumer. “It is a critical operation, and this federal funding will support its mission to advance the study of neurological diseases and injuries.”
“These federal funds will allow Winifred Masterson Burke Medical Research Institute to continue its groundbreaking clinical research,” said Senator Gillibrand. “Investing in our research and development capabilities will help advance medical treatments. I will continue to support more federal funding to advance new cutting-edge medical research around New York.”
Winifred Masterson Burke Medical Research Institute, in White Plains, New York, is a nonprofit research institute focused on neurological diseases and injuries; pushing the boundaries in the field of rehabilitation therapies.
This HHS grant funding has been allocated through the National Institute of Neurological Disorders And Stroke (NINDS). NINDS seeks fundamental knowledge about the brain and nervous system and to use that knowledge to reduce the burden of neurological disease. It seeks to support research clinics through grants and contracts as well as conducting research in its own laboratories.